BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 81 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $29,868,000 | -10.3% | 565,356 | +4.0% | 0.03% | +3.4% |
Q2 2020 | $33,297,000 | +9.0% | 543,356 | +0.6% | 0.03% | -3.3% |
Q1 2020 | $30,557,000 | -6.9% | 540,156 | -6.3% | 0.03% | +20.0% |
Q4 2019 | $32,812,000 | +7.3% | 576,247 | +0.9% | 0.02% | -3.8% |
Q3 2019 | $30,578,000 | -9.1% | 571,347 | +1.4% | 0.03% | -13.3% |
Q2 2019 | $33,629,000 | -5.8% | 563,207 | -1.6% | 0.03% | -6.2% |
Q1 2019 | $35,687,000 | +15.8% | 572,547 | +12.6% | 0.03% | -5.9% |
Q4 2018 | $30,806,000 | +0.1% | 508,347 | -3.4% | 0.03% | +6.2% |
Q3 2018 | $30,780,000 | -32.9% | 526,247 | -48.9% | 0.03% | +28.0% |
Q2 2018 | $45,896,000 | +106.2% | 1,028,900 | +105.0% | 0.02% | +4.2% |
Q1 2018 | $22,259,000 | +14.9% | 502,000 | +12.3% | 0.02% | +14.3% |
Q4 2017 | $19,377,000 | +0.3% | 447,186 | +7.7% | 0.02% | -8.7% |
Q3 2017 | $19,320,000 | -2.2% | 415,300 | +4.1% | 0.02% | -8.0% |
Q2 2017 | $19,745,000 | +2.2% | 398,800 | +13.1% | 0.02% | -7.4% |
Q1 2017 | $19,324,000 | +4.3% | 352,627 | +6.0% | 0.03% | -6.9% |
Q4 2016 | $18,534,000 | +34.4% | 332,746 | +10.2% | 0.03% | +20.8% |
Q3 2016 | $13,786,000 | +27.2% | 301,862 | +11.2% | 0.02% | +14.3% |
Q2 2016 | $10,840,000 | +24.9% | 271,400 | +8.9% | 0.02% | +31.2% |
Q1 2016 | $8,677,000 | -20.3% | 249,200 | -1.6% | 0.02% | -33.3% |
Q4 2015 | $10,887,000 | +29.8% | 253,367 | +31.5% | 0.02% | +20.0% |
Q3 2015 | $8,390,000 | -20.9% | 192,700 | -6.2% | 0.02% | -16.7% |
Q2 2015 | $10,603,000 | +51.1% | 205,489 | +14.7% | 0.02% | +60.0% |
Q1 2015 | $7,016,000 | +25.2% | 179,200 | +23.5% | 0.02% | +7.1% |
Q4 2014 | $5,604,000 | +45.6% | 145,101 | +33.1% | 0.01% | +27.3% |
Q3 2014 | $3,848,000 | +112.9% | 109,000 | +62.7% | 0.01% | +175.0% |
Q2 2014 | $1,807,000 | +368.1% | 67,009 | +349.7% | 0.00% | +300.0% |
Q1 2014 | $386,000 | +12.9% | 14,900 | -5.7% | 0.00% | 0.0% |
Q4 2013 | $342,000 | -44.7% | 15,800 | -50.2% | 0.00% | 0.0% |
Q3 2013 | $618,000 | – | 31,745 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 75,964 | $3,920,000 | 4.40% |
RK Capital | 117,206 | $6,048,000 | 1.09% |
JW Asset Management, LLC | 61,557 | $3,176,000 | 0.97% |
Elk Creek Partners, LLC | 93,879 | $4,844,000 | 0.44% |
TFS CAPITAL LLC | 61,053 | $3,150,000 | 0.31% |
NORTHPOINTE CAPITAL LLC | 46,903 | $2,420,000 | 0.28% |
EAM Investors, LLC | 42,534 | $2,195,000 | 0.26% |
Ativo Capital Management LLC | 10,592 | $613,000 | 0.22% |
RICE HALL JAMES & ASSOCIATES, LLC | 51,473 | $2,656,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 59,747 | $3,083,000 | 0.12% |